https://www.pharmexec.com/view/pharmaceutical-pricing-policy-strategic-adaptation2026-04-03T17:23:38.519Z2026-04-03T17:23:38.519Z https://www.pharmexec.com/view/pfizer-biontech-pause-covid-vaccine-study-low-enrollment-totals2026-04-03T13:48:36.424Z2026-04-03T13:48:36.424Z https://www.pharmexec.com/view/scaling-ai-s-promise-in-healthcare-the-time-is-now2026-04-03T13:15:00Z2026-04-03T13:15:00Z https://www.pharmexec.com/view/expanding-access-whole-genome-testing-children-ryan-taft-stacy-musone2026-04-03T10:00:00Z2026-04-03T10:00:00Z https://www.pharmexec.com/view/boring-al-save-healthcare-bubble-bursts2026-04-03T10:00:00Z2026-04-03T10:00:00Z https://www.pharmexec.com/view/president-trump-imposes-100-tariffs-branded2026-04-02T20:38:18.964Z2026-04-02T20:38:18.964Z https://www.pharmexec.com/view/daily-leadership-turnover-under-trump-administration2026-04-02T18:44:34.345Z2026-04-02T18:44:34.345Z https://www.pharmexec.com/view/shionogi-enters-2-billion-agreement-acquire-rights-radicava2026-04-02T13:42:39.469Z2026-04-02T13:42:39.469Z https://www.pharmexec.com/view/antitrust-cvs-healthcare-integration-ftc2026-04-02T13:00:00Z2026-04-02T13:00:00Z https://www.pharmexec.com/view/trump-administration-leadership-carousel-across-key-agencies2026-04-02T10:00:00Z2026-04-02T10:00:00Z https://www.pharmexec.com/view/pricing-mfn-impact-lindsay-bealor-greenleaf2026-04-02T10:00:00Z2026-04-02T10:00:00Z https://www.pharmexec.com/view/changing-cell-fate-yerem-yeghiazarians-md2026-04-02T10:00:00Z2026-04-02T10:00:00Z https://www.pharmexec.com/view/scaling-biopharma-requires-skills-competency-headcount2026-04-02T10:00:00Z2026-04-02T10:00:00Z https://www.pharmexec.com/view/fda-approves-foundayo-under-national-priority-voucher-program2026-04-01T18:53:52.033Z2026-04-01T18:53:52.033Z https://www.pharmexec.com/view/daily-trump-administration-delays-appeal-federal-ruling-blocking-vaccine-policy-overhaul2026-04-01T16:00:00Z2026-04-01T16:00:00Z https://www.pharmexec.com/view/being-specific-about-being-general-vaccines-edition2026-04-01T15:41:54.911Z2026-04-01T15:41:54.911Z https://www.pharmexec.com/view/trump-administration-delays-appeal-vaccine-ruling-political-pressures-mount-ahead-midterms-report2026-04-01T13:59:01.009Z2026-04-01T13:59:01.009Z https://www.pharmexec.com/view/biogen-enters-5-billion-agreement-acquire-apellis2026-04-01T13:27:12.025Z2026-04-01T13:27:12.025Z https://www.pharmexec.com/view/risk-reward-equation-research-development-leadership2026-04-01T10:00:00Z2026-04-01T10:00:00Z https://www.pharmexec.com/view/potential-fallout-mfn-policies2026-04-01T10:00:00Z2026-04-01T10:00:00Z https://www.pharmexec.com/view/daily-novo-nordisk-wegovy-subscription-program2026-03-31T18:16:31.838Z2026-03-31T18:16:31.838Z https://www.pharmexec.com/view/novo-nordisk-launches-multi-month-subscription-program-wegovy2026-03-31T15:34:22.835Z2026-03-31T15:34:22.835Z https://www.pharmexec.com/view/merck-enters-838-million-research-development-collaboration-infinimmune2026-03-31T13:54:25.794Z2026-03-31T13:54:25.794Z https://www.pharmexec.com/view/eli-lilly-enters-7-billion-agreement-acquire-centessa-pharmaceuticals-advance-sleep-wake-treatments2026-03-31T13:17:40.892Z2026-03-31T13:17:40.892Z https://www.pharmexec.com/view/the-ways-pharma-leaders-are-rewiring-their-organizations-for-launch-success2026-03-31T12:00:00Z2026-03-31T12:00:00Z https://www.pharmexec.com/view/how-pharma-leaders-must-rewire-their-organizations-for-launch-success2026-03-31T12:00:00Z2026-03-31T12:00:00Z https://www.pharmexec.com/view/damage-stressed-cell-reversed2026-03-31T10:00:00Z2026-03-31T10:00:00Z https://www.pharmexec.com/view/mfn-effects-medicare-impact-innovation2026-03-31T10:00:00Z2026-03-31T10:00:00Z https://www.pharmexec.com/view/fda-clears-high-dose-spinraza-to-enhance-sma-clinical-outcomes2026-03-30T19:07:00Z2026-03-30T19:07:00Z https://www.pharmexec.com/view/daily-eli-lilly-presses-uk-government-raise-nhs-drug-pricing2026-03-30T18:20:13.330Z2026-03-30T18:20:13.330Z https://www.pharmexec.com/view/point-of-care-isn-t-a-marketing-tactic-it-s-a-gross-to-net-strategy2026-03-30T18:17:19.159Z2026-03-30T18:17:19.159Z https://www.pharmexec.com/view/eli-lilly-seeks-agreement-uk-government-raise-prices-medicines-report2026-03-30T14:06:39.250Z2026-03-30T14:06:39.250Z https://www.pharmexec.com/view/eli-lilly-insilico-enter-2-billion-research-licensing-agreement-advance-ai-drug-discovery2026-03-30T13:28:30.066Z2026-03-30T13:28:30.066Z https://www.pharmexec.com/view/unique-soley-therapeutics-approach-developing-core-technology2026-03-30T10:00:00Z2026-03-30T10:00:00Z https://www.pharmexec.com/view/daily-novartis-acquires-excellergy-inc2026-03-27T18:40:37.625Z2026-03-27T18:40:37.625Z https://www.pharmexec.com/view/mfn-pricing-work-within-trumprx2026-03-27T18:15:13.839Z2026-03-27T18:15:13.839Z https://www.pharmexec.com/view/overcome-barriers-to-specialty-medication-adherence2026-03-27T15:55:00Z2026-03-27T15:55:00Z https://www.pharmexec.com/view/roundup-fda-approves-awiqli-treatment-type-2-diabetes-adults-kresladi-severe-leukocyte-pediatric-patients2026-03-27T14:24:20.173Z2026-03-27T14:24:20.173Z https://www.pharmexec.com/view/mergers-acquisitions-roundup-novartis-acquire-excellrgy-otsuka-acquire-transcend-therapeutics2026-03-27T13:29:55.295Z2026-03-27T13:29:55.295Z https://www.pharmexec.com/view/cancer-cells-thrive-conditions-other-cannot2026-03-27T10:00:00Z2026-03-27T10:00:00Z https://www.pharmexec.com/view/daily-trump-administration-misses-deadline-to-nominate-permanent-cdc-director2026-03-26T19:22:04.126Z2026-03-26T19:22:04.126Z https://www.pharmexec.com/view/trump-administration-pauses-search-new-head-cdc-report2026-03-26T14:15:50.882Z2026-03-26T14:15:50.882Z https://www.pharmexec.com/view/fda-approves-avlayah-treatment-hunter-syndrome2026-03-26T13:30:17.667Z2026-03-26T13:30:17.667Z https://www.pharmexec.com/view/how-companies-navigate-delivery-disturbances2026-03-26T10:00:00Z2026-03-26T10:00:00Z https://www.pharmexec.com/view/daily-fda-issues-warning-letter-to-immunitybio2026-03-25T19:30:29.926Z2026-03-25T19:30:29.926Z https://www.pharmexec.com/view/problem-health-insurance-pricing-glp1-whitney-stidom2026-03-25T19:00:09.510Z2026-03-25T19:00:09.510Z https://www.pharmexec.com/view/fda-warning-letter-immunitybio-misleading-claims-advertisement2026-03-25T14:15:23.397Z2026-03-25T14:15:23.397Z https://www.pharmexec.com/view/roundup-merck-acquire-terns-pharmaceuticals-shionogi-50-apnimed--ownership-shionogi-apnimed-sleep-science2026-03-25T13:30:50.141Z2026-03-25T13:30:50.141Z https://www.pharmexec.com/view/the-first-dose-is-everything-enhancing-adherence-and-persistence-with-noble-surestartrx-2026-03-25T12:00:00Z2026-03-25T12:00:00Z https://www.pharmexec.com/view/the-first-dose-is-everything-improving-adherence-and-persistence-with-noble-surestartrx-2026-03-25T12:00:00Z2026-03-25T12:00:00Z https://www.pharmexec.com/view/recent-regulatory-actions-impacted-rare-disease-space2026-03-25T10:00:00Z2026-03-25T10:00:00Z https://www.pharmexec.com/view/daily-bayer-shares-drop-inclusive-capital-offloads-remaining-stake2026-03-24T18:15:12.763Z2026-03-24T18:15:12.763Z https://www.pharmexec.com/view/bayer-shares-briefly-dip-activist-investor-offloads-millions-dollars-company-stock2026-03-24T17:30:43.877Z2026-03-24T17:30:43.877Z https://www.pharmexec.com/view/quotient-therapeutics-enters-research-collaboration-merck-discover-drug-targets-inflammatory-bowel-disease2026-03-24T14:00:18.593Z2026-03-24T14:00:18.593Z https://www.pharmexec.com/view/gilead-sciences-enters-2-billion-definitive-agreement-acquire-ouro-medicines2026-03-24T13:30:57.387Z2026-03-24T13:30:57.387Z https://www.pharmexec.com/view/shippers-3pls-not-possess-right-technology-move-forecasting-true-agility2026-03-24T10:00:00Z2026-03-24T10:00:00Z https://www.pharmexec.com/view/cms-asp-reporting-manufacturers2026-03-24T10:00:00Z2026-03-24T10:00:00Z https://www.pharmexec.com/view/the-competitive-edge-in-pharma-logistics-sustainability-safety-and-precision-delivery2026-03-24T04:45:00Z2026-03-24T04:45:00Z https://www.pharmexec.com/view/daily-pfizer-warns-shareholders-reject-mini-tender-offer2026-03-23T16:15:09.303Z2026-03-23T16:15:09.303Z https://www.pharmexec.com/view/pfizer-receives-unsolicited-mini-tender-offer-1-million-shares-tutanota-report2026-03-23T16:00:32.943Z2026-03-23T16:00:32.943Z https://www.pharmexec.com/view/fda-approves-expanded-indication-imcivree-treatment-hypothalamic-obesity2026-03-23T15:30:48.254Z2026-03-23T15:30:48.254Z https://www.pharmexec.com/view/what-an-end-to-end-model-changes-patients2026-03-23T10:00:00Z2026-03-23T10:00:00Z https://www.pharmexec.com/view/recent-actions-fda-provide-insight-agency-enforcement-posture2026-03-23T10:00:00Z2026-03-23T10:00:00Z https://www.pharmexec.com/view/daily-fda-approves-wegovy-hd2026-03-20T17:15:46.523Z2026-03-20T17:15:46.523Z https://www.pharmexec.com/view/hidden-gem-ai-roleplay-data-commercial-intelligence2026-03-20T15:00:00Z2026-03-20T15:00:00Z https://www.pharmexec.com/view/roundup-novartis-acquire-pan-mutant-selective-pi3k-inhibitor-synnovation-therapeutics-collegium-azstarys-corium-therapeutics2026-03-20T14:00:58.140Z2026-03-20T14:00:58.140Z https://www.pharmexec.com/view/the-only-ai-simulation-built-for-life-sciences2026-03-20T14:00:00Z2026-03-20T14:00:00Z https://www.pharmexec.com/view/fda-approves-wegovy-hd-injectable-under-accelerated-approval2026-03-20T13:30:04.596Z2026-03-20T13:30:04.596Z https://www.pharmexec.com/view/-ron-lanton-report-when-policy-becomes-capital-event2026-03-20T13:00:55.229Z2026-03-20T13:00:55.229Z https://www.pharmexec.com/view/where-precision-meets-pressure-ai-roleplay-built-for-pharma-field-teams2026-03-20T13:00:00Z2026-03-20T13:00:00Z https://www.pharmexec.com/view/ebook-you-only-get-one-shot-at-launch-make-it-count-2026-03-20T12:30:00Z2026-03-20T12:30:00Z https://www.pharmexec.com/view/proving-coaching-roi-a-pharma-field-force-transformation2026-03-20T12:00:00Z2026-03-20T12:00:00Z https://www.pharmexec.com/view/launching-with-confidence-empowering-a-specialized-field-force-for-a-pediatric-formula2026-03-20T12:00:00Z2026-03-20T12:00:00Z https://www.pharmexec.com/view/ai-automation-101-for-field-excellence-in-life-sciences2026-03-20T11:00:00Z2026-03-20T11:00:00Z https://www.pharmexec.com/view/surfacing-themes-access-usa-20262026-03-20T10:00:00Z2026-03-20T10:00:00Z https://www.pharmexec.com/view/last-mile-issues-impacting2026-03-20T10:00:00Z2026-03-20T10:00:00Z https://www.pharmexec.com/view/pharmaceutical-executive-march-2026-interactive-digital-edition2026-03-19T21:00:54.387Z2026-03-19T21:00:54.387Z https://www.pharmexec.com/view/daily-analysis-on-trumprx-list-pricing2026-03-19T18:45:50.474Z2026-03-19T18:45:50.474Z https://www.pharmexec.com/view/trumprx-selling-medicines-higher-prices-other-countries-report2026-03-19T16:15:53.316Z2026-03-19T16:15:53.316Z https://www.pharmexec.com/view/what-does-infinitus-think-relationship-between-ai-automation-human-oversight2026-03-19T15:15:15.462Z2026-03-19T15:15:15.462Z https://www.pharmexec.com/view/what-does-truly-ai-native-patient-access-infrastructure-look-like-2026-2026-03-19T15:00:05.571Z2026-03-19T15:00:05.571Z https://www.pharmexec.com/view/paysign-assists-manufacturers-making-connection-copay-program-investment-downstream-adherence2026-03-19T10:00:00Z2026-03-19T10:00:00Z https://www.pharmexec.com/view/governance-resets-companies-response-ai2026-03-19T10:00:00Z2026-03-19T10:00:00Z https://www.pharmexec.com/view/impact-innovative-cgt-trial-design-having-sponsors2026-03-19T10:00:00Z2026-03-19T10:00:00Z https://www.pharmexec.com/view/failure-rate-dcts-high2026-03-19T10:00:00Z2026-03-19T10:00:00Z https://www.pharmexec.com/view/next-threat-manufacturers-access-usa-need-preparing-for-2026-03-18T20:00:09.213Z2026-03-18T20:00:09.213Z https://www.pharmexec.com/view/what-does-next-generation-copay-assistance-look-like2026-03-18T19:45:36.318Z2026-03-18T19:45:36.318Z https://www.pharmexec.com/view/daily-federal-judge-halts-vaccine-advisory-council-appointments2026-03-18T16:30:40.450Z2026-03-18T16:30:40.450Z https://www.pharmexec.com/view/funding-roundup-excalipoint-therapeutics-completes-68-million-seed-finance-crossbow-therapeutics-raises-77-million-series-b2026-03-18T13:45:53.266Z2026-03-18T13:45:53.266Z https://www.pharmexec.com/view/fda-approves-icotyde-treatment-moderate-severe-plaque-psoriasis-adults2026-03-18T13:30:01.202Z2026-03-18T13:30:01.202Z https://www.pharmexec.com/view/how-eclinical-positioning-platform-capabilities-help-sponsors2026-03-18T10:00:00Z2026-03-18T10:00:00Z https://www.pharmexec.com/view/marketers-need-know-recent-gartner-predictions-ai-means-them2026-03-18T10:00:00Z2026-03-18T10:00:00Z https://www.pharmexec.com/view/qualified-temperature-controlled-corridors-the-future-is-here2026-03-18T04:00:00Z2026-03-18T04:00:00Z https://www.pharmexec.com/view/automation-ai-impacting-timeline-prescription-starting-treatment2026-03-17T18:30:24.765Z2026-03-17T18:30:24.765Z https://www.pharmexec.com/view/what-does-sustainable-affordability-model-current-landscape2026-03-17T17:30:35.225Z2026-03-17T17:30:35.225Z https://www.pharmexec.com/view/data-and-trust2026-03-17T16:15:35.897Z2026-03-17T16:15:35.897Z https://www.pharmexec.com/view/federal-judge-blocks-rfk-vaccine-advisory-council-appointments2026-03-17T14:00:10.170Z2026-03-17T14:00:10.170Z https://www.pharmexec.com/view/broad-llms-smaller-focused-coexist2026-03-17T10:00:00Z2026-03-17T10:00:00Z https://www.pharmexec.com/view/patient-adherence-impact-science-finance-clinical-trials2026-03-17T10:00:00Z2026-03-17T10:00:00Z https://www.pharmexec.com/view/us-measles-outbreak-highlights-growing-vaccine-hesitancy-qa-jeanne-marrazzo2026-03-17T10:00:00Z2026-03-17T10:00:00Z